32 research outputs found

    Factors Influencing Opioid Receptor Signaling to Adenylyl Cyclase.

    Full text link
    Opioids, such as morphine, signal through G protein-coupled receptors that are linked to adenylyl cyclase (AC)-inhibitory (Gi/o) heterotrimeric GTP-binding proteins. The transduction of signal from opioid receptor to G protein is dependent on the organization of proteins in the membrane and can be modulated by alterations in membrane lipids. This thesis provides evidence that mu-opioid receptors (MOR) and delta-opioid receptors (DOR) are differentially regulated by cholesterol. I have determined that cholesterol is required to stabilize MOR in a high-affinity conformation that couples to G proteins. Thus, cholesterol depletion attenuated the efficiency of MOR signaling to G proteins or AC. In contrast, DOR signaling was unaffected by removal of membrane cholesterol. Cholesterol depletion also attenuated the ability of MOR agonists to produce cellular adaptations leading to cAMP overshoot. This was true of heterologously expressed MOR in HEK293 cells, and endogenously expressed MOR in human neuroblastoma SH-SY5Y cells. Cholesterol may modulate MOR signaling by a direct interaction with the receptor or by formation of cholesterol-enriched membrane microdomains. Indeed, a portion of cell surface MOR was associated with markers of cholesterol-enriched membrane microdomains; however, these studies do not confirm that this association is responsible for the effect of cholesterol depletion on MOR signaling. In contrast, DOR was not associated with membrane microdomain markers, even after agonist treatment. MOR and DOR are thus likely not compartmentalized together within cholesterol-enriched membrane microdomains. Regardless, MOR and DOR in SH-SY5Y cells were observed to share a common pool of G proteins and AC, which resulted in occlusion of DOR agonist responses in the presence of maximally effective concentrations of MOR agonist. Moreover, this was not limited to MOR and DOR, as all Gi/o-coupled receptors endogenously expressed in SH-SY5Y cells were able to access a shared pool of AC. After chronic administration of MOR agonist, the addition of agonists to DOR, alpha2-adrenergic receptors (alpha2AR) and nociceptin/OFQ peptide receptors (NOPr) reduced the expression of MOR-mediated cAMP overshoot. Given the co-expression of alpha2AR and NOPr on MOR-containing neurons, the ability of agonists to these receptors to reduce MOR-mediated cAMP overshoot has implications in the treatment of opioid withdrawal symptoms.Ph.D.PharmacologyUniversity of Michigan, Horace H. Rackham School of Graduate Studieshttp://deepblue.lib.umich.edu/bitstream/2027.42/77937/1/elsawyer_1.pd

    Maternal mental health in primary care in five low- and middle-income countries: a situational analysis

    Full text link

    Parental Expressed Emotion During Two Forms of Family-Based Treatment for Adolescent Anorexia Nervosa.

    No full text
    High parental expressed emotion (EE), reflected by criticism or emotional over-involvement, has been related to poorer outcome in family-based treatment (FBT) for adolescent anorexia nervosa. This study assessed EE in 89 mothers and 64 fathers at baseline and end of treatment in a randomised trial comparing conjoint FBT to parent-focused FBT (PFT). Compared with conjoint FBT, PFT was associated with a decrease in maternal criticism, regardless of adolescent remission. Furthermore, an increase in maternal criticism was more likely to be observed in conjoint FBT (80%) than PFT (20%, p = 0.001). Adolescents of mothers who demonstrated an increase in EE, or remained high in EE, were less likely to remit compared with adolescents for whom EE decreased or remained low (33% and 0% vs. 43% and 50%, p = 0.03). There were no significant effects for paternal EE. The results highlight the importance of considering EE when implementing FBT for adolescents with anorexia nervosa. Copyright © 2017 John Wiley & Sons, Ltd and Eating Disorders Association

    Opioid Management in the Dying Child With Addiction

    No full text
    The dramatic increases of opioid use and misuse in the past 15 years have resulted in a focus on the responsible and judicious use of opioids. In this Ethics Rounds, the commentators analyze the case of a 16-year-old girl with lymphoma and opioid misuse whose caregiver may have diverted her opioids. She is now at the end of life and prefers to die at home. The commentators, oncologists, palliative care providers, ethicists, and a medical student agree that supporting the patient\u27s goals and practicing good opioid stewardship are not incompatible. They identify additional information that would be required to analyze the case more fully such as the nature of the evidence for misuse and diversion and whether bias inadvertently contributed to these concerns. They agree that multimodal analgesia, including but not limited to opioids, is important. Safeguards could include a contract, directly observed therapy, and/or urine drug screens. Supervision or removal of a caregiver diverting medication or admission of the patient misusing medications would be alternatives if the initial plan was unsuccessful. Such patient-centered care requires well-developed substance misuse treatment, pain management, and home hospice that are adequately reimbursed
    corecore